Wellgistics Health, Inc.
WGRX
$0.63
$0.0814.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -46.90% | 17,407.64% | 6,347.12% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -46.90% | 17,407.64% | 6,347.12% | -- | -- |
| Cost of Revenue | -46.01% | 15,367.30% | -- | -- | -- |
| Gross Profit | -55.68% | 19,553.85% | -- | -- | -- |
| SG&A Expenses | 1,622.26% | 812.22% | 39,045.49% | 309.86% | 99.11% |
| Depreciation & Amortization | 71.76% | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 365.87% | 2,052.07% | 52,796.99% | 1,422.76% | 721.29% |
| Operating Income | -1,708.13% | -859.93% | -39,183.71% | -253.17% | -93.16% |
| Income Before Tax | -1,738.15% | -1,061.85% | -38,926.35% | -302.51% | -106.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,738.15% | -1,061.85% | -38,926.35% | -302.51% | -106.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,738.15% | -1,061.85% | -38,926.35% | -302.51% | -106.69% |
| EBIT | -1,708.13% | -859.93% | -39,183.71% | -253.17% | -93.16% |
| EBITDA | -2,283.00% | -732.99% | -- | -- | -- |
| EPS Basic | -1,095.34% | -764.00% | -32,778.95% | -268.46% | -91.09% |
| Normalized Basic EPS | -1,049.38% | -765.38% | -32,433.33% | -270.00% | -91.27% |
| EPS Diluted | -1,095.34% | -764.00% | -32,778.95% | -656.43% | -91.09% |
| Normalized Diluted EPS | -1,049.38% | -765.38% | -32,433.33% | -270.00% | -91.27% |
| Average Basic Shares Outstanding | 53.66% | 34.58% | 16.09% | 9.09% | 8.24% |
| Average Diluted Shares Outstanding | 53.66% | 34.58% | 16.09% | 9.09% | 8.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |